This inventor holds 1 USPTO granted patent and 9 published patent applications. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Venkatareddy Sabbasani: Innovator in Pharmaceutical Applications
Introduction
Venkatareddy Sabbasani is an inventor based in Monrovia, MD (US). He is known for his contributions to the field of pharmaceuticals, particularly in the development of innovative compounds and methods for medical applications. Although he currently holds no granted patents, his work is significant in advancing medical science.
Latest Patent Applications
Sabbasani's latest patent applications include the preparation of isotopically labeled ketoglutarates and methods of hyperpolarization through signal amplification by reversible exchange (SABRE). This application discloses compounds of Formula (I), along with their pharmaceutically acceptable salts and methods of preparation. It also details an isotopic mixture of the compound and a pharmaceutical composition containing a hyperpolarized ketoglutarate compound. Furthermore, it outlines a method for diagnosing or monitoring cancer patients by administering a pharmaceutical composition that includes a hyperpolarized ketoglutarate compound and measuring the hyperpolarization of a compound of interest in the patient.
Another notable application is focused on mixed lineage kinase (MLK) inhibitors and methods of use. These compounds are designed to inhibit kinase activity and may be utilized to treat diseases characterized by the overexpression of one or more MLKs. The application describes the structure of these compounds according to formula I, including their stereoisomers, tautomers, or pharmaceutically acceptable salts.
Conclusion
Venkatareddy Sabbasani is an innovative inventor whose work in pharmaceutical applications holds promise for future medical advancements. His latest patent applications reflect a commitment to developing effective treatments for serious health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
